Tag

NASDAQ: GILD

GSK wins FDA approval for Hibsago in chronic hepatitis B
Adrian Kessler · Oct 21, 2026
Vir Biotechnology signs Gilead cancer deal with US$90M upfront
Adrian Kessler · Oct 15, 2026
Immunome gains FDA IND clearance for IM‑1340 solid tumour study
Adrian Kessler · Oct 1, 2026
Nuvation Bio stock climbs 16.67% on FDA approval of lung cancer drug
Joseph Morton · Sep 5, 2025